If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.10
Bid: 4.00
Ask: 4.20
Change: 0.45 (12.33%)
Spread: 0.20 (5.00%)
Open: 3.65
High: 4.20
Low: 4.10
Prev. Close: 3.65
TERN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Device Authority convertible loan note funding

28 Oct 2022 07:45

RNS Number : 4774E
Tern PLC
28 October 2022
 

 

28 October 2022

 

Tern Plc

("Tern" or the "Company")

 

Device Authority convertible loan note funding

 

Tern Plc (AIM:TERN), the company focused on value creation from Internet of Things ("IoT") technology businesses, announces that Device Authority Limited ("Device Authority"), of which Tern currently owns 53.8% of the equity, has completed a US$440,000 working capital funding in the form of unsecured convertible loan notes (the "Convertible Notes") from Tern and certain of its other existing shareholders, including Venafi and Alsop Louie Partners. Tern has subscribed for approximately US$303,401 of Convertible Notes, representing approximately 69% of the total funding.

 

The Convertible Notes and accrued interest (at a rate of 9% per annum) are repayable or convertible into Device Authority equity, at the holder's election, at the earlier of the maturity date of 30 June 2023 (the "Maturity Date"), and inter alia, on a change of control of Device Authority, or on Device Authority completing a qualifying fundraise, being a new equity financing of Device Authority which raises aggregate gross cash proceeds of at least US$5 million.

 

On a change of control of Device Authority prior to the Maturity Date, being a sale or disposal of the business as defined in Device Authority's Articles of Association, the Convertible Note holders will be entitled to a premium payment equal to 300% of the original principal amount of the Convertible Notes, or at the discretion of the Convertible Note holders the outstanding principal amount and accrued interest may be converted into the most senior class of share at a 30% discount to the price paid for the shares sold at the change of control. Additionally, subscribers to the Convertible Notes have received warrants to acquire additional Device Authority equity at a fixed price, exercisable on a change of control of Device Authority prior to the Maturity Date (the "Warrants").

 

Alternatively, should Device Authority complete a qualifying fundraise before the Maturity Date, the Convertible Notes are convertible into Device Authority equity at a 30% discount to the fundraising price. If a qualifying fundraise occurs the Warrants will expire and become non-exercisable. The Convertible Notes provide for customary events of default.

 

The valuation of Tern's holding in Device Authority, as stated in the Company's unaudited interim results for the six months to 30 June 2022, was £16.3 million. Based on Device Authority's latest statutory accounts for the year ended 31 December 2021, as at that date it had net assets of £3,824,398 and incurred a loss for the year of £2,185,382. Given the historic nature of these figures Tern does not consider this to be representative of the current business and trading performance of Device Authority.

 

Tern also currently has loans of approximately US$175,000 to Device Authority, which are short-term, non-convertible, unsecured loans.

 

Commenting Al Sisto, CEO of Tern, said:

 

"As outlined at the time of Tern's recent fundraise, the use of proceeds included capital that we can deploy to provide further funding for Tern's portfolio companies, both protecting Tern's position and providing them with the growth capital they require.

 

"We are delighted with the progress Device Authority is continuing to make and we are very happy to continue to support its working capital needs as it continues to grow its monthly recurring revenues through its subscription base and modularised licence platform, KeyScaler®.

 

"The Board remains focussed on continuing to maximise the investment value for Tern shareholders and I look forward to making further announcements in due course."

 

Enquiries

 

Tern Plc

Al Sisto (CEO)

Sarah Payne (CFO)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

David Worlidge / Alex Brearley (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

tern@investor-focus.co.uk

 

About Device Authority

 

Device Authority is a global leader in Identity and Access Management (IAM) for the IoT; focused on the automotive, medical device (IoMT) and industrial (IIoT) sectors. Device Authority's KeyScaler™ platform provides zero touch provisioning and complete automated lifecycle management for securing IoT devices and data at scale, with frictionless deployment across device provisioning, authentication, credential management, policy based end-to-end data security/encryption and secure OTA (over the air) and HSM (hardware security module) updates.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFSRIVLTFIF
Date   Source Headline
18th May 20212:00 pmRNSPrice Monitoring Extension
18th May 202111:05 amRNSSecond Price Monitoring Extn
18th May 202111:00 amRNSPrice Monitoring Extension
18th May 20219:05 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
17th May 20219:05 amRNSSecond Price Monitoring Extn
17th May 20219:00 amRNSPrice Monitoring Extension
17th May 20217:00 amRNSNotice of General Meeting
14th May 20214:40 pmRNSSecond Price Monitoring Extn
14th May 20214:35 pmRNSPrice Monitoring Extension
10th May 20214:41 pmRNSSecond Price Monitoring Extn
10th May 20214:35 pmRNSPrice Monitoring Extension
10th May 202111:05 amRNSSecond Price Monitoring Extn
10th May 202111:00 amRNSPrice Monitoring Extension
10th May 20219:05 amRNSSecond Price Monitoring Extn
10th May 20219:00 amRNSPrice Monitoring Extension
10th May 20217:00 amRNSInvestor webinar recording
7th May 20214:40 pmRNSSecond Price Monitoring Extn
7th May 20214:35 pmRNSPrice Monitoring Extension
5th May 20219:05 amRNSSecond Price Monitoring Extn
5th May 20219:00 amRNSPrice Monitoring Extension
4th May 20214:34 pmRNSResult of AGM
4th May 20217:00 amRNSAGM Statement
21st Apr 20214:41 pmRNSSecond Price Monitoring Extn
21st Apr 20214:35 pmRNSPrice Monitoring Extension
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:36 pmRNSPrice Monitoring Extension
13th Apr 20212:06 pmRNSSecond Price Monitoring Extn
13th Apr 20212:00 pmRNSPrice Monitoring Extension
13th Apr 202111:05 amRNSSecond Price Monitoring Extn
13th Apr 202111:00 amRNSPrice Monitoring Extension
13th Apr 20219:05 amRNSSecond Price Monitoring Extn
13th Apr 20219:00 amRNSPrice Monitoring Extension
6th Apr 20214:40 pmRNSSecond Price Monitoring Extn
6th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20212:06 pmRNSSecond Price Monitoring Extn
6th Apr 20212:00 pmRNSPrice Monitoring Extension
31st Mar 20217:01 amRNSDA convertible loan note maturity date extension
31st Mar 20217:00 amRNSFinal results for the year ended 31 December 2020
29th Mar 20213:40 pmRNSAIM Director Disclosure Update
29th Mar 20212:00 pmRNSPrice Monitoring Extension
25th Mar 202111:00 amRNSPrice Monitoring Extension
24th Mar 20212:06 pmRNSSecond Price Monitoring Extn
24th Mar 20212:00 pmRNSPrice Monitoring Extension
18th Mar 20214:41 pmRNSSecond Price Monitoring Extn
18th Mar 20214:35 pmRNSPrice Monitoring Extension
18th Mar 20212:06 pmRNSSecond Price Monitoring Extn
18th Mar 20212:00 pmRNSPrice Monitoring Extension
18th Mar 202111:05 amRNSSecond Price Monitoring Extn
18th Mar 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.